The Clorox Company (NYSE:CLX) Shares Bought by Mirabella Financial Services LLP

Mirabella Financial Services LLP raised its position in The Clorox Company (NYSE:CLX) by 1.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,790 shares of the company’s stock after acquiring an additional 164 shares during the period. Mirabella Financial Services LLP’s holdings in Clorox were worth $1,432,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the third quarter worth $27,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its stake in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. Family Firm Inc. acquired a new stake in shares of Clorox during the second quarter worth $31,000. Finally, Quarry LP lifted its stake in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is owned by insiders.

Clorox Stock Up 0.1 %

Shares of NYSE CLX opened at $169.30 on Monday. The company’s 50-day simple moving average is $162.78 and its 200-day simple moving average is $148.54. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.35. The firm has a market cap of $20.96 billion, a price-to-earnings ratio of 58.99, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 earnings per share. Equities analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. DA Davidson lifted their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Barclays lifted their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox currently has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.